Human BioPlazma Making HUF 5 Billion Investment to Expand Production Capacity

Biological-medicine company Human BioPlazma Gyártó és Kereskedelmi Kft is making a HUF 5 billion capacity expansion investment.

Biological-medicine company Human BioPlazma Gyártó és Kereskedelmi Kft is making a HUF 5 billion capacity expansion investment at its plant just northeast of Budapest, the Hungarian Investment and Trade Development Agency (ITD Hungary) informed MTI on March 19.
Human BioPlazma plans to complete the investment, which is expected to more than double the company's annual production capacity of plasma-based medications to 550,000 liters, in 2011. The company, which currently employs 140 people at its plant in Gödöllő, will hire around 60 workers as a result of the investment.
 

News Monitoring